BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10406188)

  • 21. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease].
    Kwon OS; Lim DY; Kwon KA; Chung MG; Park DK; Kim SS; Kim YS; Kwon SY; Koo YS; Kim YK; Choi DJ; Kim JH; Hwang YJ; Byun KS; Lee CH
    Taehan Kan Hakhoe Chi; 2003 Sep; 9(3):222-30. PubMed ID: 14515040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of matrix metalloproteinase 2 (MMP-2), membrane-type 1 MMP and tissue inhibitor of metalloproteinase 2 and activation of proMMP-2 in pancreatic duct adenocarcinomas in hamsters treated with N-nitrosobis(2-oxopropyl)amine.
    Iki K; Tsutsumi M; Kido A; Sakitani H; Takahama M; Yoshimoto M; Motoyama M; Tatsumi K; Tsunoda T; Konishi Y
    Carcinogenesis; 1999 Jul; 20(7):1323-9. PubMed ID: 10383907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas.
    Nomura H; Fujimoto N; Seiki M; Mai M; Okada Y
    Int J Cancer; 1996 Feb; 69(1):9-16. PubMed ID: 8600068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevation of serum cystatin C concentrations in patients with chronic liver disease.
    Takeuchi M; Fukuda Y; Nakano I; Katano Y; Hayakawa T
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):951-5. PubMed ID: 11507361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Nishimura Y; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):459-65. PubMed ID: 8743918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MT-MMPs) in association with MMP2 activation in injured human livers.
    Théret N; Musso O; L'Helgoualc'h A; Campion JP; Clément B
    Am J Pathol; 1998 Sep; 153(3):945-54. PubMed ID: 9736043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cells.
    Chung TW; Moon SK; Lee YC; Kim JG; Ko JH; Kim CH
    Arch Biochem Biophys; 2002 Dec; 408(2):147-54. PubMed ID: 12464265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions.
    Préaux AM; Mallat A; Nhieu JT; D'Ortho MP; Hembry RM; Mavier P
    Hepatology; 1999 Oct; 30(4):944-50. PubMed ID: 10498646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
    Arii S; Mise M; Harada T; Furutani M; Ishigami S; Niwano M; Mizumoto M; Fukumoto M; Imamura M
    Hepatology; 1996 Aug; 24(2):316-22. PubMed ID: 8690399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C.
    Lichtinghagen R; Michels D; Haberkorn CI; Arndt B; Bahr M; Flemming P; Manns MP; Boeker KH
    J Hepatol; 2001 Feb; 34(2):239-47. PubMed ID: 11281552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.
    Kuyvenhoven JP; van Hoek B; Blom E; van Duijn W; Hanemaaijer R; Verheijen JH; Lamers CB; Verspaget HW
    Thromb Haemost; 2003 Apr; 89(4):718-25. PubMed ID: 12669127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between plasma levels of matrix metalloproteinase (MMP)-9 /MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus.
    Chung TW; Kim JR; Suh JI; Lee YC; Chang YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 May; 19(5):565-71. PubMed ID: 15086601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of matrix metalloproteinase-1 for marking liver cirrhosis in chronic hepatitis C patients.
    Attallah AM; Badr El-Din NK; Omran MM; Farid K; El-Wahab AH; El-Bendary M; El-Dosoky I
    Egypt J Immunol; 2011; 18(1):33-42. PubMed ID: 23082478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinase-2 and -14 persists during early resolution of experimental liver fibrosis and might contribute to fibrolysis.
    Zhou X; Hovell CJ; Pawley S; Hutchings MI; Arthur MJ; Iredale JP; Benyon RC
    Liver Int; 2004 Oct; 24(5):492-501. PubMed ID: 15482348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C.
    Reif S; Somech R; Brazovski E; Reich R; Belson A; Konikoff FM; Kessler A
    Digestion; 2005; 71(2):124-30. PubMed ID: 15785038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases.
    Nakamura H; Fujii Y; Ohuchi E; Yamamoto E; Okada Y
    Eur J Biochem; 1998 Apr; 253(1):67-75. PubMed ID: 9578462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-prandial serum hyaluronan concentration in patients with chronic liver disease.
    Idobe Y; Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Intern Med; 1998 Jul; 37(7):568-75. PubMed ID: 9711881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pigment epithelium-derived factor and matrix metalloproteinase-9 in liver cirrhosis.
    Kozlowska J; Mikula T; Suchacz M; Jabnonska J; Stanczak W; Cianciara J; Wiercinska-Drapalo A
    Saudi J Gastroenterol; 2016; 22(5):375-379. PubMed ID: 27748324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate.
    Itoh Y; Binner S; Nagase H
    Biochem J; 1995 Jun; 308 ( Pt 2)(Pt 2):645-51. PubMed ID: 7772054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J; Bueno-Topete M; Armendariz-Borunda J
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.